Provided by Tiger Trade Technology Pte. Ltd.

INSILICO

57.600
-2.500-4.16%
Volume:4.12M
Turnover:232.69M
Market Cap:33.58B
PE:-12.86
High:57.700
Open:57.000
Low:55.700
Close:60.100
52wk High:80.900
52wk Low:29.980
Shares:583.00M
HK Float Shares:583.00M
Volume Ratio:0.34
T/O Rate:0.71%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-4.480
ROE:--
ROA:-1.36%
PB:7.82
PE(LYR):-12.86
PS:31.68

Loading ...

Citigroup Flags AI Drug Discovery as the Next Major Industry Catalyst, Names INSILICO Top Pick with a "Buy" Rating

Stock News
·
Sep 03

Movement Alert|INSILICO Rises 5.16% in Regular Trading, MSCI Index Inclusion Effect Continues Amid Strong Earnings Momentum

Market Focus
·
Sep 03

Insilico Medicine Added to HKEX Tech 100 Index After Methodology Revamp

Reuters
·
Sep 03

Insilico Shows Promise of Repeatable AI Drug-Creation

Dow Jones
·
Sep 03

Insilico Medicine Surges 5% After Unveiling Novel Alzheimer's Targets in Landmark Study

Stock News
·
Sep 01

Movement Alert|INSILICO Rises 5.49% in Regular Trading, MSCI Index Inclusion Drives Passive Fund Inflows

Market Focus
·
Sep 01

Movement Alert|INSILICO Falls 5.27% in Regular Trading, Convertible Bond Issuance Sparks Dilution Concerns

Market Focus
·
Aug 31

Insilico Medicine Cayman Enters Subscription Agreement for Us$305 Million Bonds on Aug 27

Reuters
·
Aug 28

INSILICO Announces Proposed $305M Zero-Coupon Convertible Bond Offering Due 2027

Stock News
·
Aug 28

Insilico Medicine Cayman Topco - Enters Subscription Agreement for Us$305 Mln Bonds on Aug 27, 2026

THOMSON REUTERS
·
Aug 28

Insilico Medicine Prices USD 305 Million Zero-Coupon Convertible Bond Offering Due 2027

Reuters
·
Aug 28

InSilico Medicine (SEHK:3696) Stock Turns Profitable As Revenue Jumps

Simply Wall St.
·
Aug 27

Insilico Medicine Cayman Topco Says no Dividends were Paid, Declared or Proposed During HY

Reuters
·
Aug 26

Commercialization Roadmap Validated with Three-Digit Million-Dollar Revenue: Insilico Medicine Announces Interim Results for the First Half of 2026

THOMSON REUTERS
·
Aug 26

InSilico Medicine Cayman TopCo Posts HY Profit of Us$35.5 MLN

Reuters
·
Aug 26

INSILICO Delivers 1H 2026 Turnaround with Revenue Up 2.9-Fold and First Interim Profit

Bulletin Express
·
Aug 26

Insilico Medicine Swings to USD35.54 Million Profit in H1 2026 as Revenue Quadruples

Bulletin Express
·
Aug 26

INSILICO Reports First-Half Profit Turnaround with Adjusted Earnings of $51.2 Million

Stock News
·
Aug 26

Insilico Medicine Cayman Topco Hy Profit Us$35.5 Mln

THOMSON REUTERS
·
Aug 26

Insilico Medicine Swings to FY26 H1 Profit of US$ 35.54 Million; Revenue More than Doubled to US$ 106.3 Million

Reuters
·
Aug 26